Phase IV Study of Boosted Atazanavir (ATV) Versus Non-Boosted ATV in Naive Patients
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2013
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir (Primary) ; Lamivudine; Stavudine
- Indications HIV infections
- Focus Therapeutic Use
- 01 May 2009 Week-96 body composition data published in Clinical Infectious Diseases.
- 25 Jul 2007 Results to 96 weeks were reported at IAS.
- 28 Feb 2007 Interim results at 48 weeks have been reported.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History